These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 21353499

  • 1. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W, Ghassemi AH, Hennink WE, Okonogi S.
    Colloids Surf B Biointerfaces; 2011 Jun 01; 84(2):508-14. PubMed ID: 21353499
    [Abstract] [Full Text] [Related]

  • 2. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 01; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 3. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H, Zhong H, Liu M, Xu C, Gao Y.
    Pharmazie; 2011 Sep 01; 66(9):654-61. PubMed ID: 22026119
    [Abstract] [Full Text] [Related]

  • 4. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y.
    Int J Pharm; 2008 Mar 03; 351(1-2):244-9. PubMed ID: 18024022
    [Abstract] [Full Text] [Related]

  • 5. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 03; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
    Duvvuri S, Janoria KG, Mitra AK.
    J Control Release; 2005 Nov 28; 108(2-3):282-93. PubMed ID: 16229919
    [Abstract] [Full Text] [Related]

  • 8. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X, Song SK, Zhao P, Wei LM, Jiao HS.
    Pharm Dev Technol; 2013 Nov 28; 18(5):1220-9. PubMed ID: 22295954
    [Abstract] [Full Text] [Related]

  • 9. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O, Serhatlı M, Baysal K, Baysal BM.
    J Microencapsul; 2011 Nov 28; 28(1):46-54. PubMed ID: 21171816
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fluphenazine release from biodegradable microparticles: characterization and modelling of release.
    Dunne MM, Ramtoola Z, Corrigan OI.
    J Microencapsul; 2009 Aug 28; 26(5):403-10. PubMed ID: 18785053
    [Abstract] [Full Text] [Related]

  • 12. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 28; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]

  • 13. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH, Taluja A, Knutson K, Han Bae Y.
    J Control Release; 2005 Dec 05; 109(1-3):86-100. PubMed ID: 16266769
    [Abstract] [Full Text] [Related]

  • 14. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX, Shi YN, Teng LS, Li X, Wang LX, Meng QF, Teng LR, Li YX.
    Pharm Dev Technol; 2011 Aug 05; 16(4):377-84. PubMed ID: 20370594
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid).
    Ghassemi AH, van Steenbergen MJ, Talsma H, van Nostrum CF, Jiskoot W, Crommelin DJ, Hennink WE.
    J Control Release; 2009 Aug 19; 138(1):57-63. PubMed ID: 19409427
    [Abstract] [Full Text] [Related]

  • 16. Study on in vitro release patterns of fentanyl-loaded PLGA microspheres.
    Seo SA, Khang G, Rhee JM, Kim J, Lee HB.
    J Microencapsul; 2003 Aug 19; 20(5):569-79. PubMed ID: 12909542
    [Abstract] [Full Text] [Related]

  • 17. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR, Elorza B, Torrado S, Elorza Mde L, Frutos G.
    Biomaterials; 2007 Feb 19; 28(5):877-85. PubMed ID: 17064761
    [Abstract] [Full Text] [Related]

  • 18. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS, Whateley TL.
    J Microencapsul; 1998 Feb 19; 15(6):789-801. PubMed ID: 9818956
    [Abstract] [Full Text] [Related]

  • 19. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
    D'Aurizio E, van Nostrum CF, van Steenbergen MJ, Sozio P, Siepmann F, Siepmann J, Hennink WE, Di Stefano A.
    Int J Pharm; 2011 May 16; 409(1-2):289-96. PubMed ID: 21356295
    [Abstract] [Full Text] [Related]

  • 20. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y, Woo BH, Gebrekidan S, Ahmed S, DeLuca PP.
    J Control Release; 1999 Aug 05; 60(2-3):279-86. PubMed ID: 10425333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.